A

Amylyx Pharmaceuticals

279 employees

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Neurodegenerative Diseases
Neuroscience
Amyotrophic Lateral Sclerosis
Alzheimer's Disease
ALS
Medical
Pharmaceutical
Alzheimer's

Date founded

2014

Funding rounds raised

Total raised

$135M

from 10 investors over 10 rounds

A

Amylyx Pharmaceuticals raised $135M on July 20, 2021

Investors: Woodline Partners LP, Marshall Wace, Morningside Venture Capital 晨兴资本, Viking Global Investors, Polaris Founders Capital and Perceptive Advisors

A

Amylyx Pharmaceuticals raised $5M on August 22, 2016

Investors: Lysosomal Therapeutics Inc. and ALS Investment Fund

A

Amylyx Pharmaceuticals raised $3M on July 20, 2016

Investors: ALS Finding a Cure® and The ALS Association

FAQ